Which scenario demonstrates a correct safety decision about Amorolfine 5% nail lacquer purchase according to the described age restrictions?

Which scenario demonstrates a correct safety decision about Amorolfine 5% nail lacquer purchase according to the described age restrictions?

• A. 17-year-old male – No
• B. 61-year-old female – Yes
• C. 27-year-old breastfeeding – No
• D. 47-year-old male with 3 nails – No

Answer: (B)

Amorolfine 5% nail lacquer is considered for self-care use in adults with a mild nail fungal infection confined to a small number of nails. The safety decision hinges on eligibility criteria: age (typically 18+ for OTC antifungals), pregnancy or breastfeeding status (limited data and precautionary guidance often advise avoiding or using with caution), and the extent of infection (self-care products are usually recommended only when two nails or fewer are affected; more nails usually require professional assessment). In this scenario, the 17-year-old is under the usual adult age limit, so self-care purchase isn’t appropriate. The 61-year-old female fits the adult criteria and, assuming she is not pregnant or breastfeeding and the infection involves a limited number of nails, is eligible to purchase. The 27-year-old who is breastfeeding falls into a contraindicated category for self-care use due to breastfeeding concerns. The 47-year-old male with three nails exceeds the typical self-care scope (more than two nails affected), so professional evaluation is advised rather than OTC purchase. Therefore, the correct safety decision is the 61-year-old female.

Amorolfine 5% nail lacquer is considered for self-care use in adults with a mild nail fungal infection confined to a small number of nails. The safety decision hinges on eligibility criteria: age (typically 18+ for OTC antifungals), pregnancy or breastfeeding status (limited data and precautionary guidance often advise avoiding or using with caution), and the extent of infection (self-care products are usually recommended only when two nails or fewer are affected; more nails usually require professional assessment).

In this scenario, the 17-year-old is under the usual adult age limit, so self-care purchase isn’t appropriate. The 61-year-old female fits the adult criteria and, assuming she is not pregnant or breastfeeding and the infection involves a limited number of nails, is eligible to purchase. The 27-year-old who is breastfeeding falls into a contraindicated category for self-care use due to breastfeeding concerns. The 47-year-old male with three nails exceeds the typical self-care scope (more than two nails affected), so professional evaluation is advised rather than OTC purchase. Therefore, the correct safety decision is the 61-year-old female.